APOE and atherosclerosis: Unlike before, NMN1 (300 mg/kg) was given intragastrically and daily for 2 months after 2 months of HFD-induced atherosclerosis formation in ApoE−/− mice (4 months of HFD and 2 months of NMN1 intragastrically).